Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07149376 · ClinicalTrials.gov registry record · Phase 3
To Assess the Efficacy of a Toothpaste Containing 8% Arginine as Compared to Colgate Cavity Protection Toothpaste in the Reduction of Dentinal Hypersensitivity.
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 84
- Enrollment target
NCT07149376 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 84 participants.
The verdict
NCT07149376, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 84 participants
- Enrollment target
Study Summary
The objective of this clinical investigation is to assess the efficacy of a toothpaste containing 8% arginine (Colgate-Palmolive Company, New York, NY, USA) as compared to a commercially available non-desensitizing toothpaste (Colgate Cavity Protection Toothpaste, Colgate-Palmolive Company, New York, NY, USA) in the reduction of dentinal hypersensitivity over an eight (8) week period.
Interventions
- DEVICE TOMs of Maine Sensitive SLS Free Xtra Fresh
- DRUG Colgate Cavity protection toothpaste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2025-08-18 |
| Est. Completion | 2025-10-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07149376
The ClinicalTrials.gov registry entry for NCT07149376 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TOMs of Maine Sensitive SLS Free Xtra Fresh is the first listed.
NCT07149376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07149376 about?
NCT07149376 is a clinical study titled "To Assess the Efficacy of a Toothpaste Containing 8% Arginine as Compared to Colgate Cavity Protection Toothpaste in the Reduction of Dentinal Hypersensitivity.". The objective of this clinical investigation is to assess the efficacy of a toothpaste containing 8% arginine (Colgate-Palmolive Company, New York, NY, USA) as compared to a commercially available non-desensitizing toothpaste (Colgate Cavity Protection Toothpaste, Colgate-Palmolive Company, New York...
What is the current status of trial NCT07149376?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 84 participants. The study started on 2025-08-18. Estimated completion is 2025-10-14.
What interventions are being tested in trial NCT07149376?
The interventions under investigation include: TOMs of Maine Sensitive SLS Free Xtra Fresh (DEVICE), Colgate Cavity protection toothpaste (DRUG).
Who is sponsoring clinical trial NCT07149376?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.